Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Journal of Gastrointestinal and Liver Diseases : JGLD|June 27, 2013
Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinomaHiroki Nishikawa, Yukio Osaki, Haruhiko Takeda, et al.
European Journal of Gastroenterology & Hepatology|September 14, 2016
Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesionsYuji Eso, Atsushi Takai, Haruhiko Takeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in JapanHaruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, et al.
Annals of Surgical Oncology|December 13, 2024
Aggressive Multidisciplinary Treatment for Unresectable Hepatocellular Carcinoma: The Achievement of a Pathologic Complete Response and Long-Term SurvivalTakuma Karasuyama, Takamichi Ishii, Tomoaki Yoh, et al.
Scientific Reports|February 16, 2020
Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genomeTaiki Yamashita, Haruhiko Takeda, Atsushi Takai, et al.
Journal of Cancer|July 25, 2014
Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patientsHiroki Nishikawa, Ryuichi Kita, Toru Kimura, et al.
Scientific Reports|April 1, 2017
Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencingHaruhiko Takeda, Yoshihide Ueda, Tadashi Inuzuka, et al.
Anticancer Research|November 17, 2012
Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinomaHiroki Nishikawa, Yukio Osaki, Eriko Iguchi, et al.
International Journal of Oncology|June 28, 2014
Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysisHiroki Nishikawa, Ryuichi Kita, Toru Kimura, et al.
Hepatology Communications|February 27, 2023
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencingSoichi Arasawa, Haruhiko Takeda, Atsushi Takai, et al.
Pageof 8